Navigation Links
Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg
Date:10/1/2007

Adds 22 Attorneys from McKissock & Hoffman

PHILADELPHIA, Oct. 1 /PRNewswire/ -- The national law firm of Eckert Seamans Cherin and Mellott, LLC today announced that it is forming a Professional Liability practice with the addition of 22 attorneys from McKissock & Hoffman including name partner Peter Hoffman. The group will join the firm in the continued expansion of Eckert Seamans' Philadelphia and Harrisburg offices and create a new Eckert Seamans office in West Chester, Pennsylvania, effective October 1st.

The group will consist of 9 firm members, and 13 associates and will be led by Peter Hoffman, who is nationally known and respected in the defense of professional liability cases. Mr. Hoffman will reside in Eckert Seamans' Philadelphia office. In his new role at Eckert Seamans, Mr. Hoffman will serve as Member and Chairman of the Professional Liability Practice.

In addition to Mr. Hoffman, moving to Eckert Seamans as members are Donald J. Brooks, Jr., Timothy J. Burke, John A. Filoreto, Maureen P. Fitzgerald, Eileen Lampe, Jeffrey P. Lewis, Edwin A. D. Schwartz, and Christopher Thomson. Joining the firm as associates are Ryan N. Boland, Lauren M. Burnette, Ann B. Cairns, Joseph V. Conroy, Melissa B. Gorsline, Gregory L. Kallet, Richard Kim, Steven E. McCord, Richard J. Mosback, Jr., Joan D. Plump, David J. Schertz, David M. Schwadron, and Shannon B. Stewart.

"We are extremely pleased that Peter and his group will be joining our firm in Philadelphia," said Tim Ryan, Chief Executive Officer of Eckert Seamans. "In addition to this group's track record of high performance in professional liability defense, they are a diverse group of attorneys steeped with experience and broad understanding of business law and litigation."

"These are some of the most respected attorneys in the Delaware Valley," added Albert Bixler, Member-in-Charge of Eckert Seamans' Philadelphia office. "We are very fortunate to be able to offer th
'/>"/>

SOURCE Eckert Seamans Cherin and Mellott, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...Dengue', State's war against mosquitoes has been f...ekhara Reddy on Friday formally from the Jali Hanu...tuency here. // The operation will also include a...e dustbin system of garbage collection in Hyderaba...
...o have persistent fluid in the middle ear, a condi...ikely to be harmed than helped by antihistamines a...d.// The drugs are no better than placebo in alle...ons of OME and expose children to a significant ri...
...inia University professor and two alumni have trac...a tumor that develops in the eye and often leads t...dings could someday lead to improved treatment for...th, professor of genetics and developmental biolog...
...ernment of Australia came under the glaring critic...rt in its allocation of funds for various health p...y pointed fingers at the current government for la...s spanning a spectrum of avenues that ranges from ...
Other Medicine News:Health News:YSR launches 'Operation Dengue' 2Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 2Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 3Health News:Team Tracks Genetic Origins of Eye Cancer 2Health News:Federal government blamed for allocating meager portion to health sector:ALP 2
(Date:9/4/2008)...RNewswire/ -- Southern Research Institute,today an...H) has selected,the organization to participate in...tion Center Network (MLPCN). The MLPCN -- a collab...ar Libraries Program which is,designed to benefit ...human,genome and validate future targets for drug ...
(Date:9/4/2008)...a for Ipilimumab to be Presented, PRINCETON, N.J....(Nasdaq: MEDX ) announced today that nine clinica...i-CTLA-4 antibody, in melanoma are scheduled to be... of the European Society,for Medical Oncology (ESM...Many of the following abstracts will include updat...
(Date:9/4/2008)...Schedule with Two Abstracts Accepted for Prese...er 2008, BRIDGEWATER, N.J., Sept. 4 /PRNewswire/ ...rmaceutical company focused on the treatment of,ca...d the appointment of,Peter L. Garrambone, Jr. to t...e,s career includes more than 50 pharmaceutical,tr...
(Date:9/3/2008)...ewswire-FirstCall/ -- Simcere,Pharmaceutical Group...r of,branded generic pharmaceuticals and manufactu...du (also known as Endostar) in China,announced th..., At the request of the SFDA, Simcere initiated a...afety and therapeutic efficacy of Endu, a modified...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3CSC Wins Enterprise System Development Contract From Centers for Medicare and Medicaid Services 2862 1CSC Wins Enterprise System Development Contract From Centers for Medicare and Medicaid Services 2862 2Portamedic Launches New Examiner Training Program 2857 1Portamedic Launches New Examiner Training Program 2857 2Portamedic Launches New Examiner Training Program 2857 3CalbaTech Issues Update 3B Beginning Training for Adult Stem Cell Collections in Atlanta 1051 1CalbaTech Issues Update 3B Beginning Training for Adult Stem Cell Collections in Atlanta 1051 2CalbaTech Issues Update 3B Beginning Training for Adult Stem Cell Collections in Atlanta 1051 3CalbaTech Issues Update 3B Beginning Training for Adult Stem Cell Collections in Atlanta 1051 4Gene Based Screen Spots Cervical Cancer Earlier 2855 1Gene Based Screen Spots Cervical Cancer Earlier 2855 2
...ical Data Published at the American,Society of Cli...04, 2007 /PRNewswire-FirstCall/ -- Pharmion,Corpor...se II,multi-center clinical study of Amrubicin, t...ine currently in development,for the treatment of ...vorable interim results in terms of response rate ...
...h Follicular Lymphoma Reported,Today at ASCO Annua.../ -- GlaxoSmithKline plc,announced today long-term...ne-week course of frontline treatment with the BEX... I-131 Tositumomab) in,76 patients with newly diag...NHL). This regimen was found to induce durable cli...
Other Medicine Technology:Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
The Infinity™ ALT single liquid stable reagent is intended for the in vitro quantitative determination of ALT in serum. , Infinity™ ALT reagent patented formulation not only provides ex
... analyzer. It is designed with the customer's anal...types of clinical chemistry tests, specific protei...tests, electrolytes and other user-definable appli...uitable for specialized chemistry applications out...
Inquire
ISI offers instrument cleaning brushes in a variety of lengths, diameters and composition. The long, thin brushes are perfect for cannulas and tubing. The smallest brushes are the answer for micros.
Medicine Products: